Searchable abstracts of presentations at key conferences in endocrinology

ea0016p141 | Clinical cases | ECE2008

Monogenic form of polycystic ovary syndrome due to mutation in lamin A/C gene: case report of two sisters

Forlani Giulia , Gambineri Alessandra , Patton Laura , Pagotto Uberto , Pasquali Renato

We report of two sisters with hyperandrogenism, menstrual abnormalities, and severe insulin resistance. The elder sister was seen after puberty at age 21 and she was referred for the evaluation of hirsutism and polymenorrhoea; the younger was seen earlier in life, at age 15, for the evaluation of secondary amenorrhoea. In both of them, we performed the diagnosis of polycystic ovary syndrome (PCOS) in accordance to the Rotterdam criteria. They also presented a lipodystrophic ph...

ea0016p372 | Growth factors | ECE2008

Acromegaly is associated with high plasma fibrinogen and C reactive protein values after normalization of growth hormone and IGF-1

Friedrich Nele , Nonnenberg Dennis , Spilcke-Liss Elisabeth , Volzke Henry , Dorr Marcus , Wallaschofski Henri

Background: Acromegaly is associated with increased morbidity and mortality from cardiovascular disease. Several studies indicate that reduction of growth hormone (GH) to <1 μg/l or normalization of serum IGF-I reduces mortality to expected levels. Inflammatory markers, such as C-reactive protein (CRP) or haemostatic markers, such as fibrinogen have emerged as important cardiovascular risk markers in the general population.Objective and design: ...

ea0016p570 | Obesity | ECE2008

C-reactive protein and insulin sensitivity in severe obese women with and without metabolic syndrome

Simic Maja , Micic Dragan , Sumarac-Dumanovic Mirjana , Stamenkovic-Pejkovic Danica , Jorga Jagoda , Cvijovic Goran , Kendereski Aleksandra , Zoric Svetlana

It was postulated that different therapeutic approaches could influence the markers of inflammation in obesity but it is unknown whether overweight women with and without metabolic syndrome have the same degrees of inflammatory state. The aim of our study was to compare level of hs-CRP in obese women without other components of metabolic syndrome with hs-CRP in women with metabolic syndrome (according IDF criteria). Overweight body mass index-matched women without (OW)) (n<...

ea0015p264 | Pituitary | SFEBES2008

Mechanism of C-type natriuretic peptide (CNP) stimulated phosphorylation of ERK-MAPK in pituitary GH3 somatotrophs

Jonas Kim , Thompson Iain , Fowkes Rob

CNP, the third peptide of the mammalian natriuretic peptide family, exerts its biological effects through activation of the guanylyl cyclase B (GC-B) receptor and resulting cGMP accumulation. Our previous studies reported that CNP stimulates phosphorylation of MAPK family proteins in GH3 somatotrophs. This present study aimed to further characterise the mechanism of CNP-stimulated ERK phosphorylation and resulting biological consequences in GH3 cells. Western blot analyses sho...

ea0014p68 | (1) | ECE2007

Circulating retinol binding protein 4 and protein C inhibitor are not related to insulin resistance

Promintzer Miriam , Krebs Michael , Luger Anton , Bischof Martin Georg , Nowotny Peter , Binder Christoph , Esterbauer Harald , Anderwald Christian

Recent data suggest that circulating retinol binding protein-4 (RBP4) is involved in the pathogenesis of insulin resistance in rodents and humans. Moreover, protein C inhibitor (PCI) which specifically binds retinoic acid was found to be increased in myocardial infarction survivors who are also insulin-resistant.Therefore, we investigated the association of insulin resistance with plasma retinol binding factors (RBP4 and PCI active antigen) in nondiabeti...

ea0014p96 | (1) | ECE2007

High-sensitivity C-reactive protein in diabetes mellitus type II according to micral test findings

Hambali Zarida

Cardiac complications account for three quarter of deaths among diabetic patients. Many studies have shown that high-sensitivity C-reactive protein (hs-CRP) correlated with the inflammatory process of atherosclerosis in the coronary artery. This study is designed to determine the levels of plasma hs-CRP in Type II diabetic patients with microalbuminuria and its association with other biochemical markers used for diabetic monitoring. All biochemical parameters were analyzed usi...

ea0014p100 | (1) | ECE2007

Inhibition of C17,20-lyase activity by new 17β-exo-heterocyclic androsterone derivatives

Szécsi Mihály , Tóth István , Wölfling János , Schneider Gyula , Julesz János

17α-Hydroxylase-C17,20-lyase (P45017α) is a key regulator enzyme of the steroid hormone biosynthesis in both the adrenals and the testes. Inhibition of this enzyme can block androgen synthesis in an early step, and may thereby be useful in the treatment of prostatic carcinoma, which is androgen-dependent in the majority of cases. Abiraterone and its analogues have been found strong inhibitors of P45017α suggesting that steroid de...

ea0011p329 | Diabetes, metabolism and cardiovascular | ECE2006

Association of c-reactive protein with insulin resistance in first degree relatives of diabetic patients

Gulcelik NE , Serter R , Ozkaya M , Aral Y

Objective: C-reactive protein (CRP) is a nontraditional risk factor that predicts cardiovascular disease but its relationship between diabetes and insulin resistance is not well documented. We evaluated the association of CRP levels and insulin resistance in a group of patients at high risk for diabetes.Materials and methods: In this study we evaluated 22 first degree relatives of type 2 diabetic patients with impaired glucose tolerance test (Group 1) an...

ea0009p14 | Diabetes and metabolism | BES2005

Effects of hormone replacement therapy and raloxifene on C-reactive protein in healthy postmenopausal women

Kumru S , Yildiz M , Godekmerdan A , Yilmaz B

We have investigated the effects of estradiol valerat plus dienogest and raloxifene on serum high sensitive C - reactive protein (hsCRP) levels in healthy postmenopausal women. This study was approved by the local ethics committee. Forty eight healthy postmenopausal women were randomly divided into three groups. While group I (n=16) was given 60 mg raloxifene, group II (n=16) received continuously 2 mg estradiol valerat plus 2 mg dienogest. Group III (n=16) received no medicat...

ea0008oc20 | Young Endocrinologist Session | SFE2004

Sp1/Sp3, GnRH and PACAP involvement in C-type natriuretic peptide (CNP/Nppc) expression and action in gonadotrophs

Fowkes RC , Burrin JM , McArdle CA , Steinhelper ME

C-type natriuretic peptide (CNP) is encoded by the Nppcgene and is abundant in the hypothalamus and anterior pituitary gonadotrophs. Nppc deletion leads to skeletal deformity, dwarfism, early death and female infertility. To investigate regulation of Nppcexpression and action in the hypothalamic-pituitary-gonadal axis, we investigated transcriptional regulation of the Nppc promoter in alphaT3-1 gonadotroph cells by transient transfection of reporter...